Ingrid Vreys

928 total citations
12 papers, 726 citations indexed

About

Ingrid Vreys is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Ingrid Vreys has authored 12 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Ingrid Vreys's work include Platelet Disorders and Treatments (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Ingrid Vreys is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Ingrid Vreys collaborates with scholars based in Belgium, United States and Netherlands. Ingrid Vreys's co-authors include Jos Vermylen, Marc Hoylaerts, D Collen, Hans Deckmyn, Miłosz Jankowski, Gregor Theilmeier, Carine Michiels, Christine Wittevrongel, Jef Arnout and Erik Spaepen and has published in prestigious journals such as Blood, Circulation Research and Biochemical Journal.

In The Last Decade

Ingrid Vreys

12 papers receiving 704 citations

Peers

Ingrid Vreys
Elizabeth B. Kelso United Kingdom
Lynette Dunning United Kingdom
Crystal L. Piffath United States
Xiaohe Cai United States
Brenda Finney United Kingdom
Elizabeth B. Kelso United Kingdom
Ingrid Vreys
Citations per year, relative to Ingrid Vreys Ingrid Vreys (= 1×) peers Elizabeth B. Kelso

Countries citing papers authored by Ingrid Vreys

Since Specialization
Citations

This map shows the geographic impact of Ingrid Vreys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Vreys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Vreys more than expected).

Fields of papers citing papers by Ingrid Vreys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Vreys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Vreys. The network helps show where Ingrid Vreys may publish in the future.

Co-authorship network of co-authors of Ingrid Vreys

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Vreys. A scholar is included among the top collaborators of Ingrid Vreys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Vreys. Ingrid Vreys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Oury, Cécile, Marijke J. E. Kuijpers, Emese Tóth-Zsámboki, et al.. (2003). Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood. 101(10). 3969–3976. 105 indexed citations
2.
Jankowski, Miłosz, Ingrid Vreys, Christine Wittevrongel, et al.. (2002). Thrombogenicity of β2-glycoprotein I–dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood. 101(1). 157–162. 130 indexed citations
3.
Theilmeier, Gregor, Carine Michiels, Erik Spaepen, et al.. (2002). Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood. 99(12). 4486–4493. 134 indexed citations
4.
Kawasaki, Tomihisa, Mieke Dewerchin, H.R. Lijnen, et al.. (2001). Mouse Carotid Artery Ligation Induces Platelet-Leukocyte–Dependent Luminal Fibrin, Required for Neointima Development. Circulation Research. 88(2). 159–166. 61 indexed citations
5.
Yamamoto, Hiroshi, Ingrid Vreys, Jean Marie Stassen, et al.. (1998). Antagonism of vWF Inhibits both Injury Induced Arterial and Venous Thrombosis in the Hamster. Thrombosis and Haemostasis. 79(1). 202–210. 53 indexed citations
6.
Hoylaerts, Marc, et al.. (1997). von Willebrand factor binds to native collagen VI primarily via its A1 domain. Biochemical Journal. 324(1). 185–191. 83 indexed citations
7.
Stassen, Jean Marie, Anne‐Marie Lambeir, Ingrid Vreys, et al.. (1995). Characterisation of a Novel Series of Aprotinin-derived Anticoagulants. Thrombosis and Haemostasis. 74(2). 655–659. 5 indexed citations
8.
9.
Collen, Désiré, Hua Rong Lu, Jean–Marie Stassen, et al.. (1994). Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis.. PubMed. 71(1). 95–102. 46 indexed citations
10.
Collen, D, Hua Rong Lu, Jean–Marie Stassen, et al.. (1994). Antithrombotic Effects and Bleeding Time Prolongation with Synthetic Platelet GPIIb/llla Inhibitors in Animal Models of Platelet-Mediated Thrombosis. Thrombosis and Haemostasis. 71(1). 95–102. 43 indexed citations
11.
Stassen, JM, Hans Deckmyn, Ingrid Vreys, & Anne‐Marie Lambeir. (1993). Comparative properties of a factor-xa inhibitor, 4c2 (an aprotonin analog), heparin and hirudin in a hamster femoral vein platelet-rich mural thrombosis model. Thrombosis and Haemostasis. 69(6). 588–588. 2 indexed citations
12.
Imura, Yoshimi, Jean–Marie Stassen, Ingrid Vreys, et al.. (1992). Synergistic Antithrombotic Properties of G4120, a RGD-Containing Synthetic Peptide, and Argatroban, a Synthetic Thrombin Inhibitor, in a Hamster Femoral Vein Platelet-Rich Thrombosis Model. Thrombosis and Haemostasis. 68(3). 336–340. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026